Page last updated: 2024-10-25

ciclopirox and Opportunistic Infections

ciclopirox has been researched along with Opportunistic Infections in 1 studies

Opportunistic Infections: An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression.

Research Excerpts

ExcerptRelevanceReference
" Flucytosine (5FC) has shown synergistic effect with AmB for treatment of some fungal infections, such as cryptococcosis, but again, its price is a limitation for its use in many regions."3.96Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and ( Agreda-Mellon, D; de Oliveira, HC; García-Cambero, JP; Lucio, J; Mendes-Giannini, MJS; Rossi, SA; Zaragoza, O, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Rossi, SA1
de Oliveira, HC1
Agreda-Mellon, D1
Lucio, J1
Mendes-Giannini, MJS1
García-Cambero, JP1
Zaragoza, O1

Other Studies

1 other study available for ciclopirox and Opportunistic Infections

ArticleYear
Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
    Antimicrobial agents and chemotherapy, 2020, 03-24, Volume: 64, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Auranofin; Candida albicans; Candidiasis; Cell Line; Cic

2020